Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
actin alpha 2, smooth muscle | 0.508 | 0.846 | 0.93 |
|
disease | 0.600 | strong | 1.000 | 12 | 2 | 2009 | 2018 | ||||||||
|
ring finger protein 213 | 0.628 | 0.538 | 4.9E-55 |
|
disease | 0.500 | None | 0.953 | 85 | 5 | 2011 | 2020 | ||||||||
|
BRCA1/BRCA2-containing complex subunit 3 | 0.686 | 0.500 | 6.4E-03 |
|
disease | 0.340 | limited | 1.000 | 4 | 0 | 2011 | 2017 | ||||||||
|
elastin | 0.415 | 0.885 | 2.1E-14 |
|
disease | 0.320 | limited | 1.000 | 2 | 0 | 1993 | 2016 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.320 | limited | 1.000 | 2 | 0 | 2011 | 2019 | ||||||||
|
major histocompatibility complex, class II, DQ beta 1 | 0.407 | 0.885 | 8.9E-03 |
|
disease | 0.310 | limited | 1.000 | 1 | 0 | 1997 | 2019 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
disease | 0.110 | None | 1.000 | 1 | 3 | 2014 | 2018 | ||||||||
|
emerin | 0.542 | 0.731 | 0.93 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 2017 | 2019 | ||||||||
|
growth control, Y chromosome influenced | 0.631 | 0.615 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 2017 | 2019 | |||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2011 | 2019 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
disease | 0.050 | None | 0.800 | 5 | 1 | 1997 | 2013 | ||||||||
|
monocyte to macrophage differentiation associated | 0.647 | 0.577 | 1.3E-04 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2009 | 2019 | ||||||||
|
guanylate cyclase 1 soluble subunit alpha 1 | 0.686 | 0.577 | 3.1E-08 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2014 | 2018 | ||||||||
|
desmocollin 3 | 0.570 | 0.808 | 2.3E-21 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2017 | 2019 | ||||||||
|
argininosuccinate lyase | 0.593 | 0.731 | 8.6E-10 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2017 | 2019 | ||||||||
|
actin beta | 0.325 | 0.923 | 0.99 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2011 | 2017 | ||||||||
|
TIMP metallopeptidase inhibitor 2 | 0.425 | 0.846 | 0.79 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2006 | 2014 | ||||||||
|
matrix metallopeptidase 3 | 0.408 | 0.885 | 5.7E-15 |
|
disease | 0.030 | None | 0.667 | 3 | 1 | 2010 | 2015 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
disease | 0.030 | None | 1.000 | 3 | 1 | 2014 | 2018 | ||||||||
|
caveolin 1 | 0.388 | 0.885 | 8.3E-03 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2016 | 2019 | ||||||||
|
platelet derived growth factor receptor beta | 0.416 | 0.846 | 0.90 |
|
disease | 0.020 | None | 0.500 | 2 | 1 | 2010 | 2013 | ||||||||
|
kinase insert domain receptor | 0.378 | 0.885 | 1.00 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2012 | 2016 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2006 | 2019 | ||||||||
|
Cbl proto-oncogene | 0.527 | 0.769 | 6.1E-04 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2015 | 2017 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2016 | 2017 |